The sterol C-24 methyltransferase encoding gene, erg6 , is essential for viability of Aspergillus species
Jinhong Xie,Jeffrey M. Rybak,Adela Martin-Vicente,Xabier Guruceaga,Harrison I. Thorn,Ashley V. Nywening,Wenbo Ge,Josie E. Parker,Steven L. Kelly,P. David Rogers,Jarrod R. Fortwendel
DOI: https://doi.org/10.1038/s41467-024-48767-3
IF: 16.6
2024-05-21
Nature Communications
Abstract:Triazoles, the most widely used class of antifungal drugs, inhibit the biosynthesis of ergosterol, a crucial component of the fungal plasma membrane. Inhibition of a separate ergosterol biosynthetic step, catalyzed by the sterol C-24 methyltransferase Erg6, reduces the virulence of pathogenic yeasts, but its effects on filamentous fungal pathogens like Aspergillus fumigatus remain unexplored. Here, we show that the lipid droplet-associated enzyme Erg6 is essential for the viability of A. fumigatus and other Aspergillus species, including A. lentulus , A. terreus , and A. nidulans. Downregulation of erg6 causes loss of sterol-rich membrane domains required for apical extension of hyphae, as well as altered sterol profiles consistent with the Erg6 enzyme functioning upstream of the triazole drug target, Cyp51A/Cyp51B. Unexpectedly, erg6 -repressed strains display wild-type susceptibility against the ergosterol-active triazole and polyene antifungals. Finally, we show that erg6 repression results in significant reduction in mortality in a murine model of invasive aspergillosis. Taken together with recent studies, our work supports Erg6 as a potentially pan-fungal drug target.
multidisciplinary sciences